Literature DB >> 26933742

Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.

Liza Shrestha1, Hardik J Patel1, Gabriela Chiosis2.   

Abstract

The chaperome is a large and diverse protein machinery composed of chaperone proteins and a variety of helpers, such as the co-chaperones, folding enzymes, and scaffolding and adapter proteins. Heat shock protein 90s and 70s (HSP90s and HSP70s), the most abundant chaperome members in human cells, are also the most complex. As we have learned to appreciate, their functions are context dependent and manifested through a variety of conformations that each recruit a subset of co-chaperone, scaffolding, and folding proteins and which are further diversified by the posttranslational modifications each carry, making their study through classic genetic and biochemical techniques quite a challenge. Chemical biology tools and techniques have been developed over the years to help decipher the complexities of the HSPs and this review provides an overview of such efforts with focus on HSP90 and HSP70.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26933742      PMCID: PMC4779498          DOI: 10.1016/j.chembiol.2015.12.006

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  115 in total

1.  Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Authors:  Kamalika Moulick; James H Ahn; Hongliang Zong; Anna Rodina; Leandro Cerchietti; Erica M Gomes DaGama; Eloisi Caldas-Lopes; Kristin Beebe; Fabiana Perna; Katerina Hatzi; Ly P Vu; Xinyang Zhao; Danuta Zatorska; Tony Taldone; Peter Smith-Jones; Mary Alpaugh; Steven S Gross; Nagavarakishore Pillarsetty; Thomas Ku; Jason S Lewis; Steven M Larson; Ross Levine; Hediye Erdjument-Bromage; Monica L Guzman; Stephen D Nimer; Ari Melnick; Len Neckers; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

Review 2.  GrpE, Hsp110/Grp170, HspBP1/Sil1 and BAG domain proteins: nucleotide exchange factors for Hsp70 molecular chaperones.

Authors:  Andreas Bracher; Jacob Verghese
Journal:  Subcell Biochem       Date:  2015

3.  Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.

Authors:  Aikaterini Rousaki; Yoshinari Miyata; Umesh K Jinwal; Chad A Dickey; Jason E Gestwicki; Erik R P Zuiderweg
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

4.  C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.

Authors:  P Muller; E Ruckova; P Halada; P J Coates; R Hrstka; D P Lane; B Vojtesek
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

5.  Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone.

Authors:  Timothy O Street; Laura A Lavery; David A Agard
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

Review 6.  Chaperoning oncogenes: Hsp90 as a target of geldanamycin.

Authors:  L Neckers
Journal:  Handb Exp Pharmacol       Date:  2006

7.  Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.

Authors:  Karen L Soldano; Arif Jivan; Christopher V Nicchitta; Daniel T Gewirth
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

8.  A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.

Authors:  Andrew J Massey; Douglas S Williamson; Helen Browne; James B Murray; Pawel Dokurno; Terry Shaw; Alba T Macias; Zoe Daniels; Stephanie Geoffroy; Melanie Dopson; Paul Lavan; Natalia Matassova; Geraint L Francis; Christopher J Graham; Rachel Parsons; Yikang Wang; Antony Padfield; Mike Comer; Martin J Drysdale; Mike Wood
Journal:  Cancer Chemother Pharmacol       Date:  2009-12-13       Impact factor: 3.333

9.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

Authors:  K Koya; Y Li; H Wang; T Ukai; N Tatsuta; M Kawakami; L B Chen
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.

Authors:  Jared J Barrott; Philip F Hughes; Takuya Osada; Xiao-Yi Yang; Zachary C Hartman; David R Loiselle; Neil L Spector; Len Neckers; Narasimhan Rajaram; Fangyao Hu; Nimmi Ramanujam; Ganesan Vaidyanathan; Michael R Zalutsky; H Kim Lyerly; Timothy A Haystead
Journal:  Chem Biol       Date:  2013-09-12
View more
  38 in total

Review 1.  A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.

Authors:  Tony Taldone; Tai Wang; Anna Rodina; Naga Vara Kishore Pillarsetty; Chander S Digwal; Sahil Sharma; Pengrong Yan; Suhasini Joshi; Piyusha P Pagare; Alexander Bolaender; Gail J Roboz; Monica L Guzman; Gabriela Chiosis
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

2.  Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

Authors:  Lisa Giulino-Roth; Herman J van Besien; Tanner Dalton; Jennifer E Totonchy; Anna Rodina; Tony Taldone; Alexander Bolaender; Hediye Erdjument-Bromage; Jouliana Sadek; Amy Chadburn; Matthew J Barth; Filemon S Dela Cruz; Allison Rainey; Andrew L Kung; Gabriela Chiosis; Ethel Cesarman
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

Review 3.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

4.  Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.

Authors:  Antonella Paladino; Mark R Woodford; Sarah J Backe; Rebecca A Sager; Priyanka Kancherla; Michael A Daneshvar; Victor Z Chen; Dimitra Bourboulia; Elham F Ahanin; Chrisostomos Prodromou; Greta Bergamaschi; Alessandro Strada; Marina Cretich; Alessandro Gori; Marina Veronesi; Tiziano Bandiera; Renzo Vanna; Gennady Bratslavsky; Stefano A Serapian; Mehdi Mollapour; Giorgio Colombo
Journal:  Chemistry       Date:  2020-07-08       Impact factor: 5.236

Review 5.  Inhibitors and chemical probes for molecular chaperone networks.

Authors:  Jason E Gestwicki; Hao Shao
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

6.  [Mechanism of heat shock protein 90 for regulating 26S proteasome in hyperthermia].

Authors:  Qing-Rong Ma; Pei-Zhi Yu; Fan Zhang; Yu-Qi Li; Shu Yang; Xian-Yi Mo; Kai-Lan Mo; Ying Ding; Si-Ze Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

7.  Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations.

Authors:  Marie Ménade; Guennadi Kozlov; Jean-François Trempe; Harshit Pande; Solomon Shenker; Sihara Wickremasinghe; Xinlu Li; Hamed Hojjat; Marie-Josée Dicaire; Bernard Brais; Peter S McPherson; Michael J H Wong; Jason C Young; Kalle Gehring
Journal:  J Biol Chem       Date:  2018-06-26       Impact factor: 5.157

Review 8.  Chaperome Networks - Redundancy and Implications for Cancer Treatment.

Authors:  Pengrong Yan; Tai Wang; Monica L Guzman; Radu I Peter; Gabriela Chiosis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Cell-surface HSP70 associates with thrombomodulin in endothelial cells.

Authors:  Gabriela Venturini; Ana I S Moretti; Thaís L S Araujo; Leonardo Y Tanaka; Alexandre Costa Pereira; Francisco R M Laurindo
Journal:  Cell Stress Chaperones       Date:  2019-01-15       Impact factor: 3.667

Review 10.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.